§ BIOTECHNOLOGY
USD · Biotechnology

TNGX

TANGO THERAPEUTICS INC
USDSector · BiotechnologyBeta · 1.17
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
182 increased/new, 58 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B1.67EPS (TTM)-0.83
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
RTW INVESTMENTS, LP13.3M2.8%+792%
ADAGE CAPITAL PARTNERS GP, L.L.C.12.8M0.4%+21%
Boxer Capital Management, LLC10.9M29.9%±0%
TCG Crossover Management, LLC10.5M6.3%−17%
Fidelity Management9.9M0.0%+245%
BlackRock, Inc.8.7M0.0%+2%
◇ AC INTELLIGENCE

Top institutional owners for TNGX as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER106.1% · 133 holders
QUALITY / COMPOUNDER12.8% · 17 holders
DEALER / BANK9.6% · 18 holders
PASSIVE / INDEX9.2% · 9 holders
TACTICAL / MACRO3.2% · 4 holders
INCOME / DEFENSIVE0.2% · 9 holders
SYSTEMATIC / QUANT0.1% · 5 holders
GROWTH / MOMENTUM0.1% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for TNGX in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention TNGX yet.